Joe Amabile Shares Brain Tumor Diagnosis and Treatment

The television personality underwent surgery after a routine full-body scan identified a malignant tumor.

Updated on Oct. 31, 2026 in Cancer

Bold flat-color editorial illustration of a sterile medical corridor, representing the diagnostic journey of modern proactive healthcare. — Television personality Joe Amabile is recovering following surgery to remove a malignant astrocytoma, which was detected during a proactive full-body MRI scan. AI Illustration. Upload story photo >

Live Poll

Do you believe elective full-body MRI scans are a necessary part of a proactive health routine?

In July 2026, 40-year-old Joe Amabile revealed that he was diagnosed with a low-grade astrocytoma. The tumor, described as blueberry-sized, was discovered during a proactive Prenuvo full-body MRI scan and subsequently removed via surgery.

Why it matters

The case highlights the growing debate surrounding proactive full-body MRI scans, which are not typically covered by insurance and can lead to complex diagnostic journeys. While these scans can detect potential issues, they also raise concerns regarding the psychological and physical burden of follow-up procedures for asymptomatic patients.

A 2020 study found that 95% of asymptomatic patients undergoing full-body scans had abnormal findings, though only 1.8% were ultimately diagnosed with cancer. Costs for these scans generally range from several hundred to several thousand dollars.

The players

Joe Amabile

Joe Amabile is a television personality who publicly documented his experience with a brain tumor diagnosis.

Prenuvo

Prenuvo is a company that provides diagnostic imaging services including full-body MRI scans.

The details

Following his surgery, Amabile began a daily regimen involving an IDH inhibitor drug to manage the condition. His recovery plan includes follow-up MRIs every three months for the first year, transitioning to twice-yearly scans in the second year and annual checkups thereafter.

A 2020 study examined abnormal findings in asymptomatic patients.
A February 2025 JAMA study analyzed influencer posts regarding full-body MRIs.
Joe Amabile revealed his astrocytoma diagnosis in July 2026.

Health Landscape

The story follows a pattern set by the February 2025 JAMA study, which documented how 87% of influencer posts regarding MRI scans were positive, illustrating the prevalence of promotional content surrounding elective medical procedures. This aligns with broader shifts in how patients learn about and seek out non-traditional or proactive medical imaging services.

Because full-body MRI scans are generally not covered by insurance, individuals must be prepared to pay out-of-pocket costs ranging from hundreds to thousands of dollars. Patients should also discuss the likelihood of incidental findings with their physicians to understand the potential for follow-up testing.

The takeaway

Proactive health screenings can be life-saving but often lead to complex medical decisions regarding incidental findings. It is essential to consult with a medical professional to weigh the diagnostic benefits against the potential for unnecessary follow-up procedures.